132 related articles for article (PubMed ID: 3680600)
1. Prediction of individual dosage of nortriptyline in depressed elderly outpatients.
Schneider LS; Cooper TB; Staples FR; Sloane RB
J Clin Psychopharmacol; 1987 Oct; 7(5):311-4. PubMed ID: 3680600
[TBL] [Abstract][Full Text] [Related]
2. Prediction of steady-state plasma levels of amitriptyline and nortriptyline from a single dose 24 hr. level in depressed patients.
Brunswick DJ; Amsterdam J; Schless A; Rothbart M; Sandler K; Mendels J
J Clin Psychiatry; 1980 Oct; 41(10):337-40. PubMed ID: 7430077
[TBL] [Abstract][Full Text] [Related]
3. Child and adolescent nortriptyline single dose kinetics predict steady state plasma levels and suggested dose: preliminary data.
Geller B; Cooper TB; Chestnut EC; Anker JA; Price DT; Yates E
J Clin Psychopharmacol; 1985 Jun; 5(3):154-8. PubMed ID: 3998205
[TBL] [Abstract][Full Text] [Related]
4. Electrocardiographic changes with nortriptyline and 10-hydroxynortriptyline in elderly depressed outpatients.
Schneider LS; Cooper TB; Severson JA; Zemplenyi T; Sloane RB
J Clin Psychopharmacol; 1988 Dec; 8(6):402-8. PubMed ID: 3069881
[TBL] [Abstract][Full Text] [Related]
5. Relationship of hydroxynortriptyline to nortriptyline concentration and creatinine clearance in depressed elderly outpatients.
Schneider LS; Cooper TB; Suckow RF; Lyness SA; Haugen C; Palmer R; Sloane RB
J Clin Psychopharmacol; 1990 Oct; 10(5):333-7. PubMed ID: 2258449
[TBL] [Abstract][Full Text] [Related]
6. Targeting therapeutic plasma levels of nortriptyline from test dose plasma concentrations.
Clothier J; Reed K
J Clin Psychopharmacol; 1984 Aug; 4(4):216-7. PubMed ID: 6470195
[TBL] [Abstract][Full Text] [Related]
7. Nortriptyline therapy in elderly patients: dosage prediction from plasma concentration at 24 hours after a single 50 mg dose.
Dawling S; Crome P; Heyer EJ; Lewis RR
Br J Psychiatry; 1981 Nov; 139():413-6. PubMed ID: 7332844
[TBL] [Abstract][Full Text] [Related]
8. [Tricyclic antidepressants dosage and depressed elderly inpatients: a retrospective pharmaco-epidemiologic study].
Ballon N; Siobud-Dorocant E; Even C; Slama F; Dardennes R
Encephale; 2001; 27(4):373-6. PubMed ID: 11686060
[TBL] [Abstract][Full Text] [Related]
9. Valpromide increases the plasma concentrations of amitriptyline and its metabolite nortriptyline in depressive patients.
Vandel S; Bertschy G; Jounet JM; Allers G
Ther Drug Monit; 1988; 10(4):386-9. PubMed ID: 3144066
[TBL] [Abstract][Full Text] [Related]
10. Predictors of therapeutic effects in amitriptyline treatment--1. Plasma drug levels.
Franke L; Schewe HJ; Uebelhack R; Müller-Oerlinghausen B
Pharmacopsychiatry; 2003 Jul; 36(4):134-42. PubMed ID: 12905099
[TBL] [Abstract][Full Text] [Related]
11. Prediction of steady-state plasma levels of doxepin and imipramine from single dose levels in depressed outpatients.
Hrdina PD; Bakish D; Swenson S; Lapierre YD
J Psychiatry Neurosci; 1991 Mar; 16(1):25-9. PubMed ID: 2049367
[TBL] [Abstract][Full Text] [Related]
12. Nortriptyline capacity-limited metabolism: a case report.
Browne JL; Perry PJ; Taylor JW; Sieleni BA; Kronfol Z
J Clin Psychopharmacol; 1984 Dec; 4(6):322-5. PubMed ID: 6511999
[TBL] [Abstract][Full Text] [Related]
13. Double-blind placebo-controlled study of nortriptyline in depressed adolescents using a "fixed plasma level" design.
Geller B; Cooper TB; Graham DL; Marsteller FA; Bryant DM
Psychopharmacol Bull; 1990; 26(1):85-90. PubMed ID: 2196631
[TBL] [Abstract][Full Text] [Related]
14. Verbal memory and plasma drug concentrations in elderly depressives treated with nortriptyline.
Young RC; Mattis S; Alexopoulos GS; Meyers BS; Shindledecker RD; Dhar AK
Psychopharmacol Bull; 1991; 27(3):291-4. PubMed ID: 1775601
[TBL] [Abstract][Full Text] [Related]
15. [The use of low-dose amitriptyline in psychogeriatrics. A clinical, pharmacokinetic and pharmacogenetic study].
Schnyder C; Baumann P; Jonzier-Perey M; Koeb L; Wertheimer J
Schweiz Med Wochenschr; 1985 Aug; 115(33):1128-34. PubMed ID: 4035330
[TBL] [Abstract][Full Text] [Related]
16. Nortriptyline pharmacokinetics and plasma levels: implications for clinical practice.
Rubin EH; Biggs JT; Preskorn SH
J Clin Psychiatry; 1985 Oct; 46(10):418-24. PubMed ID: 3900052
[TBL] [Abstract][Full Text] [Related]
17. Clinical relevance of serum nortriptyline and 10-hydroxy-nortriptyline measurements in the depressed elderly: a multicenter pharmacokinetic and pharmacodynamic study.
Kin NM; Klitgaard N; Nair NP; Amin M; Kragh-Sorensen P; Schwariz G; Ahmed SK; Holm P; Katona C; Stage K
Neuropsychopharmacology; 1996 Jul; 15(1):1-6. PubMed ID: 8797186
[TBL] [Abstract][Full Text] [Related]
18. Rapid desipramine dose adjustment using 24-hour levels.
Nelson JC; Jatlow PI; Mazure C
J Clin Psychopharmacol; 1987 Apr; 7(2):72-7. PubMed ID: 3584524
[TBL] [Abstract][Full Text] [Related]
19. The effect of nortriptyline in elderly patients with cardiac conduction disease.
Dietch JT; Fine M
J Clin Psychiatry; 1990 Feb; 51(2):65-7. PubMed ID: 2298706
[TBL] [Abstract][Full Text] [Related]
20. The prediction of tricyclic antidepressant plasma concentrations.
Braithwaite RA; Dawling S; Montgomery SA; McAuley R
Postgrad Med J; 1980; 56 Suppl 1():112-4. PubMed ID: 7393819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
